Biotech Stock News (VRX) (ONTX) (BXLT) (SHPG)

Valeant Pharmaceuticals (NYSE:VRX) On Monday March 4, 2016 Valeant Pharmaceuticals fell down 7% in the morning as the company announced that it will have to delay its financial results. This left investors jittery and in panic mode, because they had and still have no clue why earnings are being pushed back so much. One possible … Read more

Tuesday Talk: Biotech News 2/23/15 to 2/27/15

Valeant Pharmaceuticals (VRX) & Salix Pharmaceuticals (SLXP) Valeant Pharmaceuticals had agreed to buy Salix Pharmaceuticals for about $10.4 billion dollars in an all cash type deal. Valeant currently has many approved drugs in various areas such as: skin, eyes, and oral type drugs. This addition of Salix Pharmaceuticals will give Valeant access to a gastrointestinal … Read more